Repare Therapeutics Inc. (RPTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 55.56M |
| Enterprise Value | -27.23M |
| P/E Ratio | -1.58 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 9.62 |
| Price/Book Ratio | 0.99 |
| Enterprise/Revenue | 3.52 |
| Enterprise/EBITDA | -0.55 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -6.08 |
| Operating Margin | -6.33 |
| Return On Assets | -0.57 |
| Return On Equity | -0.58 |
| Revenue | 53.48M |
| Revenue/Share | 0.28 |
| Gross Profit | 40.1M |
| EBITDA | -90.22M |
| Net Income | -84.69M |
| Diluted EPS | -2 |
| Total Cash | 112.6M |
| Total Cash/Share | 2.62 |
| Total Debt | 342,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.71 |
| Book Value Per Share | 2.68 |
| 52-Week Change | 120.83 |
| 52-Week High | 2.66 |
| 52-Week Low | 0.89 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 1.75 |
| Average Volume | 1.18M |
| Shares Outstanding | 43.11M |
| % Held by Institutions | 58.57 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |